Tianjin Tianmao Technology Development Corp Ltd

Country/Region: China     State/Province: Tianjin

Main Products: DEFLAZACORT, DESONIDE, BUDESONIDE, HYDROCORTISONE SODIUM SUCCINATE, BETAMETAHSONE, PREDNICARBATE, PREDNISOLONE, DEFLAZACORT

Company Introduction
Best quality and durable stationery from renowned Manufacturer of Fluticasone, serving the market since 2003. TIANJIN TIANMAO TECHNOLOGY DEVELOPMENT CORP LTD operates under Agency, dealing in DEFLAZACORT,DESONIDE,BUDESONIDE,HYDROCORTISONE SODIUM SUCCINATE,BETAMETAHSONE,PREDNICARBATE,PREDNISOLONE of all kinds, ensuring top quality and make. Our product line is specifically designed for school and workplaces, being supplied to not only domestic market but across borders as well constituting Australia,Canada,Germany,Netherlands,United Kingdom export market share. Our corporate venture was introduced in TIANJIN, Tianjin, China, with initial fortune worth Above US$100 Million. We understand the value of trust that our customers place in us and being a reputable Exporter of Fluticasone and we make sure to look after production and shipping processes with strict quality maintenance. TIANJIN TIANMAO TECHNOLOGY DEVELOPMENT CORP LTD is a Professional Association company, holding 17 Years of export experience helping us excel in the market with vast awareness and knowledge of a best product line. As of now, we have reached annual export value of US$2.5 Million - US$5 Million catering Approx More Than 1 Billion US Dollar of annual revenue.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2003, 2003

Legal Status: Agency

Ownership: Professional Association

Employees: Above 1000 People

Factory Size: 10, 000-30, 000 square meters

R&D Team Size: Fewer than 5

Certifications: ISO10012

Contact Information

Contact Person: LI MA

Designation: Marketing Manager

Department: Industrial designer

Telephone: 86-22-23709100

Business Information

Main Markets: Germany (28%) Australia (26%) Canada (24%) United Kingdom (20%) Netherlands (17%)

Export Focus: Australia, Canada, Germany, Netherlands, United Kingdom

Contract Services: OEM Service Offered

Trade & Financial Information

Annual Revenue: Approx More Than 1 Billion US Dollar

Registered Capital: Above US$100 Million

Export Percentage: 81% - 90%

Payment Terms: Bank wire (T/T), Doc Against Payment (D/P), PayPal, Western Union (WU)

Product Showcase
DEFLAZACORT
DESONIDE
BUDESONIDE
HYDROCORTISONE SODIUM SUCCINATE
BETAMETAHSONE
PREDNICARBATE
PREDNISOLONE
DEFLAZACORT

CL-Link > Health & Medicines in China Health & Medicines in Tianjin Medicines in China Medicines in Tianjin